id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2824558,b0ffeaa9-e4dc-4860-a099-8aaf83936f10,Q2,RICCHETTI INCORPORATED,62778,"NEUROCRINE BIOSCIENCES, INC.",2022,second_quarter,MMM,"Issues related to drug pricing and access, and Medicare and Medicaid reimbursement; Issues related Medicare Part D reform and its impact on Low Income Subsidy (LIS) patients","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-18T14:14:23-04:00